JUNE 4, 2026 AT 11:32 AM

Biogen Inc. (BIIB) announced today that the US FDA has granted salanersen breakthrough therapy designation for the treatment of spinal muscular atrophy SMA

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.

Open Dashboard

#BIOGEN IDEC INC#BIIB.US#FDA#EQUITIES#EU SESSION#US SESSION#BIOTECHNOLOGY#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#BIOGEN INC#BIIB#US EQUITIES